Recommended Screening: Regular screening for prostate cancer is recommended to increase the chance of detecting cancer in its early, most curable stages. Screening includes a digital rectal examination as well as blood tests to examine levels of prostate-specific antigen (PSA), a protein whose increased presence in the blood may signal the development of prostate cancer or other conditions. To learn how often these screening tests are recommended, visit the American Cancer Society Web site .
Services Available: NYU Medical Center offers screening tests for prostate cancer. For more information and to make an appointment, please call the NYU Physician Referral Service at 1-888-7-NYU-MED (1-888-769-8633). You may also visit the Department of Urology .
Each year, the Perlmutter Cancer Center provides prostate cancer screenings at no cost to the patient. These screenings are offered by the physicians of NYU Medical Center. For more information, visit the Community Events and Programs section  of this Web site, or call the Community Outreach and Education program at 212-263-6342.
Prevention: In the area of prevention, our researchers are leading studies to investigate green tea, soy protein, and selenium compounds as possible preventive agents for prostate cancer. Research is also under way to see if dutasteride, a drug that works like finasteride (Proscar, widely used to treat benign prostate enlargement) can reduce the risk of prostate cancer development in men with elevated PSA levels. We are also assessing whether a drug called toremifene may reverse prostate intraepithelial neoplasia (PIN), a form of prostate precancer.